PRIA Logo™
KentuckyHB 7882025 Regular SessionHouse

AN ACT relating to buprenorphine products.

Sponsored By: Kimberly Poore Moser (Republican)

Failed

Drugs and MedicinesHealth and Medical ServicesNursesPhysicians and PractitionersSubstance AbuseAdministrative Regulations and ProceedingsBoards and Commissions

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Free to download

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Kimberly Poore Moser

    Republican • House

Cosponsors

  • Daniel Grossberg

    Democrat • House

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. returned to Health Services (H)

    3/5/2025House

  2. 1st reading

    3/5/2025House

  3. taken from Health Services (H)

    3/5/2025House

  4. to Health Services (H)

    2/26/2025House

  5. to Committee on Committees (H)

    2/19/2025House

  6. introduced in House

    2/19/2025House

Bill Text

  • Introduced

    2/19/2025

    PDF

Related Bills

Back to State Legislation